Ligand validation:2JE9

XMM: 5-bromo-4-chloro-1H-indol-3-yl alpha-D-mannopyranoside

XMM is a Ligand Of Interest in 2JE9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2JE9_XMM_A_1242	66%	39%	0.118	0.923	1.06	1.3	-	5	0	0	100%	1
2JE9_XMM_D_1242	57%	45%	0.135	0.91	1.09	1.04	1	1	0	0	100%	1
2JE9_XMM_B_1242	43%	30%	0.132	0.856	1.37	1.4	1	3	0	0	100%	1
2JE9_XMM_C_1242	16%	38%	0.192	0.76	1.12	1.32	1	2	0	0	100%	1
2JE7_XMM_A_1242	96%	52%	0.07	0.978	0.96	0.9	1	-	0	0	100%	1
5TG3_XMM_A_303	94%	31%	0.071	0.971	1.37	1.37	3	3	0	0	100%	1
2JEC_XMM_A_242	92%	46%	0.081	0.97	1.15	0.96	1	-	0	0	100%	1
8UX7_XMM_A_303	80%	52%	0.108	0.958	0.59	1.26	-	3	0	0	100%	1
6CJ9_XMM_A_303	64%	2%	0.112	0.91	2.24	4.18	8	4	0	0	100%	1
4K21_XMM_A_303	97%	21%	0.068	0.983	2.09	1.22	8	4	0	0	100%	0.9691
3U4X_XMM_A_239	92%	41%	0.091	0.98	0.89	1.39	2	4	0	0	100%	1
4L8Q_XMM_A_303	87%	36%	0.099	0.971	0.93	1.59	-	5	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.